When did Vericel report Q4 2024 earnings?

Vericel (VCEL) reported Q4 2024 earnings on February 27, 2025 before market open.

What were Vericel's Q4 2024 revenue and EPS?

Vericel reported revenue of $75.4M and eps of $0.38 for Q4 2024.

Did Vericel beat estimates in Q4 2024?

Revenue beat the consensus estimate of $58.1M by $17.3M. EPS beat the consensus estimate of $0.31 by $0.07.

Where can I find Vericel's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001628280-25-008447) directly on SEC EDGAR. The filing index links above go to sec.gov.

Vericel VCEL Q4 2024 Annual earnings

Reported February 27, 2025 · Before market open

Revenue$75.4MBeat by $17.3M

EPS$0.38Beat by $0.07

Revenue estimate$58.1M

EPS estimate$0.31

Next report

Jul 30, 2026 (Tomorrow)

Revenue estimate$72.7M

EPS estimate-$0.04

Financials

Q4 2024

Income statement

See full

Revenue$75.4M+16.0%

Gross profit$58.5M+20.6%

Operating income$18.5M—

Net income$19.8M—

EPS (diluted)$0.39—

Balance sheet

See full

Cash & equivalents$85.0M-2.1%

Total debt$99.7M+13.2%

Total equity$292.0M+29.2%

Total assets$432.7M+22.4%

Cash flow

See full

Operating cash flow$22.2M+121%

CapEx$13.8M+76.0%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.71B+59.5%

Enterprise value$2.72B+60.2%

P/E261.6×—

P/S11.4×+2.8×

Profitability

See full

Gross margin72.6%+3.9pp

Operating margin1.9%—

Net margin4.4%—

Returns & leverage

See full

Return on equity4%—

Debt / equity0.3×0.0×

Current ratio4.2×-0.3×

Segments

By product

See full

M A C I Implants and kits$68.3M+20.6%

MACI implants, kits, and instruments$51.6M+36.7%

Epicel$6.0M-22.5%

Biopsy kits$566.0K-0.7%

Versus estimates

Revenue

Q1 2026$68.4MBeat by $4.7M Q4 2025$92.9MBeat by $1.9M Q3 2025$67.5MMiss by $25.2M Q2 2025$63.2MMiss by $1.3M Q1 2025$52.6MMiss by $12.2M

Q4 2024$75.4MBeat by $17.3M

Diluted EPS

Q1 2026-$0.12Beat by $0.03 Q4 2025$0.45In line Q3 2025$0.10Beat by $0.12 Q2 2025-$0.01Beat by $0.03 Q1 2025-$0.23Miss by $0.14

Q4 2024$0.38Beat by $0.07

Ask the moment Vericel reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Vericel report Q4 2024 earnings?: Vericel (VCEL) reported Q4 2024 earnings on February 27, 2025 before market open.
What were Vericel's Q4 2024 revenue and EPS?: Vericel reported revenue of $75.4M and eps of $0.38 for Q4 2024.
Did Vericel beat estimates in Q4 2024?: Revenue beat the consensus estimate of $58.1M by $17.3M. EPS beat the consensus estimate of $0.31 by $0.07.
Where can I find Vericel's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001628280-25-008447) directly on SEC EDGAR. The filing index links above go to sec.gov.